|
High $0.00 |
Low $0.00 |
Trades 3 |
Turnover $1,511 |
Volume 672,333 |
| 30 June 2023 at 1:49pm | ||||
|
Market Cap (6-Jul) $5,671,263 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.077 |
52w Low $0.036 |
P/E - |
EPS 0 |
GTG released this announcement to the ASX on 10 March 2021, 16:37. The announcement is not marked as price sensitive, and is 1 page(s) in length and 140.18kb in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
At the date of this announcement, GTG was 0.002% short sold according to ASIC data. It was ranked the 635th most shorted stock on the ASX. It is now ranked as the 603rd most shorted stock on the ASX with 0.004% of total shares short sold as of the latest reported data (23 March 2021).
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| Section 708A Notice | 10 March 2021, 16:37 |
| Appendix 2A | 10 March 2021, 16:34 |
| GTG presenting at HC Wainwright Conference | 9 March 2021, 17:15 |
| GTG signs 3-year US licence agreement for COVID risk test | 3 March 2021, 14:49 |
You must be logged in to post a reply.
Genetic Technologies 